Related Experiment Video
Updated: Jul 13, 2025

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
Published on: September 22, 2023
Allergy and Asthma Prevalence and Management Across Nasal Polyp Subtypes
Kody G Bolk1, Thomas S Edwards1, Sarah K Wise1
1Department of Otolaryngology-Head and Neck Surgery, Emory University Hospital Midtown, 550 Peachtree Street NE, MOT Suite 1135, Atlanta, GA 30308, USA.
Managing allergy and asthma is crucial for chronic rhinosinusitis with nasal polyposis patients. Addressing these conditions alongside treatments like topical steroids optimizes outcomes in aspirin-exacerbated respiratory disease and fungal rhinosinusitis.
Area of Science:
- Otolaryngology
- Allergology
- Pulmonology
Background:
- Chronic rhinosinusitis with nasal polyposis (CRSwNP) exhibits varied allergy and asthma prevalence.
- Specific patient subsets, including those with aspirin-exacerbated respiratory disease (AERD), allergic fungal rhinosinusitis (AFRS), and central compartment atopic disease (CCAD), present unique challenges.
Purpose of the Study:
- To investigate the integrated management of allergy and asthma in CRSwNP patients.
- To highlight the importance of considering upper and lower airway inflammation in treatment strategies.
Main Methods:
- Literature review and clinical case analysis focusing on CRSwNP management.
- Examination of treatment modalities including topical steroids, nasal rinses, and endoscopic sinus surgery.
- Assessment of the impact of co-existing allergy and asthma on patient outcomes.
Main Results:
- Allergy and asthma are significant comorbidities in CRSwNP, influencing disease presentation and treatment response.
- Standard CRSwNP treatments may be insufficient without addressing underlying allergic and asthmatic components.
- Optimized outcomes are associated with a comprehensive approach targeting all inflammatory pathways.
Conclusions:
- Effective management of CRSwNP necessitates a holistic approach that includes addressing comorbid allergy and asthma.
- Integrated treatment plans are essential for improving patient quality of life and reducing disease recurrence.
- Further research into tailored management strategies for specific CRSwNP phenotypes is warranted.
More Related Videos
03:40Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
11:54Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
Published on: January 21, 2018
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management
First, in...
Asthma-I: Introduction